Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2013
05/23/2013US20130130268 Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof
05/23/2013US20130130252 Identification of pold2 sequences
05/23/2013US20130130251 Identification of snare ykt6 sequences
05/23/2013US20130130250 Isolated glucokinase genomic polynucleotide fragments from chromosome 7
05/23/2013US20130130233 Monoclonal antibodies to human immunodeficiency virus and uses thereof
05/23/2013US20130129787 Adhesive complex coacervates produced from electrostatically associated block copolymers and methods for making and using the same
05/23/2013US20130129779 Cattle reproductive disease vaccines
05/23/2013US20130129777 Conjugates of plasmodium falciparum surface proteins as malaria vaccines
05/23/2013US20130129767 Vaccines against pregnancy-associated malaria
05/23/2013US20130129766 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
05/23/2013US20130129765 Compositions and Methods for Stimulating Immune Response Against Moraxella Catarrhalis
05/23/2013US20130129764 Compositions and methods to detect various infectious organisms
05/23/2013US20130129763 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
05/23/2013US20130129761 Influenza virus vaccine and uses thereof
05/23/2013US20130129760 Polypeptides
05/23/2013US20130129754 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
05/23/2013US20130129751 Method for treating prostatitis utilizing pore-forming protein proaerolysin
05/23/2013US20130129742 Human leukolectins and uses thereof
05/23/2013US20130129741 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands
05/23/2013US20130129740 Nucleic acids and proteins from streptococcus groups a and b
05/23/2013US20130129737 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof
05/23/2013US20130129726 Peptide having cell membrane penetrating activity
05/23/2013US20130129724 Dual function proteins for treating metabolic disorders
05/23/2013US20130129715 Use of anti-plac1 protein antibodies as biomarkers of infertility, diagnostic kit for the detection of the immune response against plac1 and use of plac1 protein in therapeutic and contraceptive fields
05/23/2013US20130129710 Hemostatic compositions
05/23/2013US20130129709 Fraction of Proteins and Peptides Derived from Egg White and Protein Derived From Egg White and Use Thereof as Anti Listeria Agent
05/23/2013US20130129693 Antidotes for factor xa inhibitors and methods of using the same
05/23/2013US20130129682 Haemophilus parasuis polypeptides and methods of use
05/23/2013US20130129679 Interferon beta as antibacterial agents
05/23/2013US20130129672 Mutants of interleukin- 1 receptor antagonist and uses thereof
05/23/2013US20130129670 Macrophage activating factor for use in the treatment of chronic fatigue syndrome (cfs) and cfs-related diseases and disorders
05/23/2013CA2856329A1 Compositions and methods for treating glioma
05/23/2013CA2855818A1 Methods of treating cancer
05/23/2013CA2855770A1 Pegylated c-peptide
05/23/2013CA2855675A1 Conjugates of gm-csf and il-7, compositions and methods related thereto
05/23/2013CA2855653A1 Methods and products for increasing frataxin levels and uses thereof
05/23/2013CA2855545A1 Oral leptin formulations and uses thereof
05/23/2013CA2855152A1 Collagen-like silk genes
05/23/2013CA2854819A1 Modified dna-binding proteins and uses thereof
05/23/2013CA2854809A1 Compositions and methods for treating autoimmune and inflammatory disorders
05/22/2013EP2594583A1 Transferrin variants and conugates
05/22/2013EP2594582A2 Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens
05/22/2013EP2594581A2 Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens
05/22/2013EP2594580A1 Method for diagnosing propionibacterium bacteria infections
05/22/2013EP2594579A1 Truncated human papillomavirus type 58 l1 protein
05/22/2013EP2594578A1 Replikin peptides directed against pathogenic infections of invertebrates in aquaculture
05/22/2013EP2594576A1 Improved vaccines and methods for using the same
05/22/2013EP2594281A1 Insulin-lipid complex, preparation method therefor, and preparation thereof
05/22/2013EP2593792A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof
05/22/2013EP2593791A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof
05/22/2013EP2593550A1 Diagnostic method for colitis
05/22/2013EP2593548A1 Human papillomavirus e7 antigen compositions and uses thereof
05/22/2013EP2593546A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
05/22/2013EP2593473A1 Asparaginase from basidiomycetes
05/22/2013EP2593472A1 Ancestral proteins
05/22/2013EP2593470A1 Deamidated barley proteins
05/22/2013EP2593468A2 Isolated polynucleotides and methods and plants using same for regulating plant acidity
05/22/2013EP2593136A1 Live attenuated parvovirus
05/22/2013EP2593135A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus
05/22/2013EP2593130A2 Stabilized factor viii variants
05/22/2013EP2593127A1 Anti-angiogenic agent and method of using such agent
05/22/2013CN1732014B Templated native silk smectic gels
05/22/2013CN1643143B Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
05/22/2013CN103119168A Human papillomavirus E7 antigen compositions and uses thereof
05/22/2013CN103119157A Variants of glucoamylase
05/22/2013CN103119153A Anticaries compositions and probiotics/prebiotics
05/22/2013CN103119058A Manufacture of inter -alpha - inhibitor proteins (IAIP) from plasma
05/22/2013CN103119057A Amide-based insulin prodrugs
05/22/2013CN103119056A Improved process for production of recombinant human growth hormone
05/22/2013CN103119055A Pegylated C-Peptide
05/22/2013CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof
05/22/2013CN103119053A Process for the production of cells which are capable of converting arabinose
05/22/2013CN103119052A Peptide derivatives, preparation thereof and uses thereof
05/22/2013CN103118704A Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus
05/22/2013CN103118702A Therapeutic vaccination against active tuberculosis
05/22/2013CN103118701A OSPA chimeras and use thereof in vaccines
05/22/2013CN103118698A Neuregulin isoforms, neuregulin polypeptides and uses thereof
05/22/2013CN103118697A Immunogenic compositions and methods for treating neoplasia
05/22/2013CN103114115A Method for preparing recombinant human granulocyte colony stimulating factors screened by microorganisms, and medicament composition and preparation thereof
05/22/2013CN103114104A Anticancer peptide gene recombination and anticancer application thereof
05/22/2013CN103114098A Response gene BrPHYB for controlling shadowing property of cabbage and application thereof
05/22/2013CN103114095A Trichina AN1 type zinc finger protein-2B recombinant protein antigen and preparation method thereof
05/22/2013CN103114094A Amphioxus endonuclear protein, and expression gene and application thereof
05/22/2013CN103113509A Regeneration-type affinity precipitation agent by using L-thyroxine as affinity ligand, preparation method and application thereof and relevant regeneration-type polymer
05/22/2013CN103113468A Anti-tumor protein
05/22/2013CN103113467A PirB extracellular polypeptide and application
05/22/2013CN103113466A Recombinant human interferon beta-1b modified by polyethylene glycol and preparation method of recombinant human interferon beta-1b
05/22/2013CN103113465A Interferon-alpha mutant and polyethylene glycol derivative thereof
05/22/2013CN103113464A Natural human erythropoietin analogue
05/22/2013CN103113463A Nuclear reprogramming factor
05/22/2013CN103113462A Shark glycoprotein, and preparation method and application thereof
05/22/2013CN103113461A Novel defensin BD2, and gene and application thereof
05/22/2013CN103113460A Extraction process for fructus cannabis globulin
05/22/2013CN103113459A Method for continuously producing whey soy proteins through soy whey water
05/22/2013CN103113258A Sudan I derivatives as well as preparation method and application thereof
05/22/2013CN103110938A Autologous biomedical fibrin glue preparation for plugging digestive tract fistula as well as preparation method and application of autologous biomedical fibrin glue preparation
05/22/2013CN102718857B Denatured protein powder and brain protein hydrolyzate prepared from same
05/22/2013CN102627693B High-affinity penicillin binding protein and application thereof
05/22/2013CN102586265B Method for diminishing plant organs
05/22/2013CN102586264B Method for improving plant yield